Advances in bioresorbable triboelectric nanogenerators
With the growing demand for next-generation health care, the integration of electronic
components into implantable medical devices (IMDs) has become a vital factor in achieving …
components into implantable medical devices (IMDs) has become a vital factor in achieving …
Single administration vaccines: delivery challenges, in vivo performance, and translational considerations
Introduction With a limited global supply of vaccines and an increasing vaccine hesitancy,
improving vaccination coverage has become a priority. Current vaccination regimes require …
improving vaccination coverage has become a priority. Current vaccination regimes require …
In vitro degradation of 3D-printed poly (L-lactide-Co-glycolic acid) scaffolds for tissue engineering applications
A Ghosh Dastidar, SA Clarke, E Larrañeta, F Buchanan… - Polymers, 2023 - mdpi.com
The creation of scaffolds for cartilage tissue engineering has faced significant challenges in
developing constructs that can provide sufficient biomechanical support and offer suitable …
developing constructs that can provide sufficient biomechanical support and offer suitable …
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis
Tuberculosis (TB) is a communicable disease caused by Mycobacterium tuberculosis (Mtb)
and is a major cause of morbidity and mortality. Successful treatment requires strict …
and is a major cause of morbidity and mortality. Successful treatment requires strict …
Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: in vitro evaluation
Release testing of parental controlled release microspheres is an essential step in
controlling quality and predicting the duration of efficacy. In the first of a two-part study, we …
controlling quality and predicting the duration of efficacy. In the first of a two-part study, we …
Poly(lactic-co-glycolic acid) Nanoparticles for the Encapsulation and Gastrointestinal Release of Vitamin B9 and Vitamin B12
MJ Ramalho, JA Loureiro… - ACS Applied Nano …, 2021 - ACS Publications
Deficiencies of vitamin B9 (VB9) and vitamin B12 (VB12) are very common among aged
adults due to their poor oral bioavailability. However, the poor stability of these vitamins …
adults due to their poor oral bioavailability. However, the poor stability of these vitamins …
Preparation, characterization, and enhanced antimicrobial activity: quercetin-loaded PLGA nanoparticles against foodborne pathogens
T ARASOĞLU, S Derman… - Turkish Journal of …, 2017 - journals.tubitak.gov.tr
The use of quercetin as a bioflavonoid is becoming increasingly common in food industries
even though poor water solubility, instability, absorption, and permeability have limited its …
even though poor water solubility, instability, absorption, and permeability have limited its …
Paclitaxel delivery system based on poly (lactide-co-glycolide) microparticles and chitosan thermo-sensitive gel for mammary adenocarcinoma treatment
JI Pesoa, MJ Rico, VR Rozados… - Journal of Pharmacy …, 2018 - academic.oup.com
Objectives To evaluate the combination of more than one release system in the same
formulation as a useful strategy to achieve paclitaxel delivery in a more sustained and …
formulation as a useful strategy to achieve paclitaxel delivery in a more sustained and …
Kinetic degradation and biocompatibility evaluation of polycaprolactone‐based biologics delivery matrices for regenerative engineering of the rotator cuff
Whereas synthetic biodegradable polymers have been successfully applied for the delivery
of biologics in other tissues, the anatomical complexity, poor blood supply, and reduced …
of biologics in other tissues, the anatomical complexity, poor blood supply, and reduced …
Biodegradation study of PLGA as an injectable in situ depot-forming implant for controlled release of paclitaxel
MS Amini-Fazl - Polymer Bulletin, 2021 - Springer
In this study, poly (d, l-lactide-co-glycolide), PLGA, was developed as an in situ forming
implants (ISFIs) to improve the therapeutic efficiency and to devoid the adverse effects of the …
implants (ISFIs) to improve the therapeutic efficiency and to devoid the adverse effects of the …